Search
AGENIX LIMITED (AGX)

AGENIX LIMITED (AGX)

  Print

Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Agenix Limited
Stock Code: AGX
Website: www.agenix.com
GICS Sub-Industry: Biotechnology
Market Cap ($M): 9
Equiv. Shares (M): 756

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
$ 0.012 $ 0.012 $ 0.012 $ 0.012 $ 0.012 170,000 0%

Current Broker Consensus Recommendation more
Recommendation: Hold
Recommendation Date: 19th Dec 2008
12 Month Target Price (average): $0
Brokers Surveyed: 1

Company Overview

Business Description:
Agenix Limited (AGX) is an Australian based international biotechnology company with a wholly owned subsidiary in China. The company has two core businesses: Innovative Biopharmaceuticals and Medical Diagnostics


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2011  A -2.7 -0.4 -180.0 0.0 0.0 0.0 --
2010  A 2.5 0.5 -- 3.2 0.0 0.0 --
2009  A -8.0 -1.8 -- 0.0 0.0 0.0 --
Source: Morningstar analyst estimates.

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2009 A 2010 F 2011 F 2009 A 2010 F 2011 F 2009 A 2010 F 2011 F
Agenix (AGX) $11 M -- -- -- -- -- -- 0.0000 -- --
CSL (CSL) $15,810 M 0.0602 0.1144 0.0939 17.5346 15.7345 14.3843 0.0263 0.0284 0.0319
Mesoblast (MSB) $1,835 M -- -- -- -- 3250.0000 -- 0.0000 0.0000 0.0000
Prima Biomed (PRR) $170 M -- -- -- -- -- -- 0.0000 -- --
Starpharma (SPL) $379 M -- -- -- -- -- -- 0.0000 0.0000 0.0000

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
AGX -- -- 4.44 -- --
Market 1.21 11.1 1.09 1.30 2.68
Sector 0.75 16.9 2.28 1.55 5.95

Directors
Name Position Start Date
Mr Nicholas Weston Executive Chairman 22 August 2008
Mr Anthony Lee Vui Han Non-Executive Director 27 August 2007
Mr Christopher McNamara Non-Executive Director 21 February 2008

Management
Name Position
Tang Wen Sen Chairman of Agenix Biopharmaceutical (Shanghai) Co Ltd
Joanna Wu Chief Financial Officer
Gary Taylor Chief Financial Officer,Company Secretary
John Tong General Manager
John Yue Manager New Drug Development

Substantial Shareholders
Holding Name
135,907,376 (18.19%) Annmac Investments Pty Ltd
41,666,666 (5.58%) OKS AGX INC.
90,000,000 (12.04%) Tang Wen Seng

Calendar of Events
Date Event
26 September 2012 Report (Annual)
29 August 2012 Report (Prelim)
16 February 2012 Report (Interim)
Search for Managed Funds, Superannuation Funds and Retirement Funds Find a Managed Fund Reduce your fees and save money on your Managed Funds with our 100% Entry Fee Rebate 100% Entry Fee Rebate

Login
Email
Password
     Log me in automatically in future
Forgotten password? | Secure Login | Terms & Conditions
Free Membership

Membership benefits...

  • 100% entry fee rebates
  • Cash back on your managed fund investments with our innovative TrailCap™ program
  • Independent research on...
    • over 1,000 managed funds
    • over 300 ASX-listed Companies
    • top performing suburbs/postcodes
  • Access to IPOs/floats & other investment offers
  • Superior investment tools...
    • Portfolio manager
    • Watchlists
    • Alerts
  • Regular investment e-newsletter

Advertisement

Portfolio / Watchlist

Start a new portfolio / view your existing portfolio.
Track all your assets and manage your investments easily.

Trade Shares Online from $19.95^

eNewsletter

Keep up to date with new investments and important news - subscribe to our FREE weekly eNewsletters. Sign up now!

Free Guides

The Essential Guide to Leveraged Trading using CFDs

An educational booklet that outlines the different types of Contracts for Difference (CFDs) available in Australia.

More details...


News

Obama hoses down talk of Israeli strikes against Iran

The Age 7/02/2012 | ISRAEL'S Foreign Minister was headed for Washington overnight amid signs that the US and its Middle East ally hold diverging views on how best to resolve the standoff over Iran's disputed nuclear program.

Ryan misses out on Perpetual love

Sydney Morning Herald 7/02/2012 | There will be fewer love hearts and boxes of chocolates this Valentine's Day for the short-lived chief executive of Perpetual Limited, Chris Ryan.

Hotel upgrades aimed at rising domestic demand

Sydney Morning Herald 7/02/2012 | HOTEL owners and operators are preparing for a busy year of openings and renovations as demand increases from domestic travellers.

Catch some rays and head into blue heaven

The Age 6/02/2012 | AUSTRALIA has a reputation for embracing technological developments quickly. We had a record take-up of VHS, DVD and widescreen television, and it is widely claimed that the Land of Oz has more home theatres per head of population than anywhere else in the world.

In the final analysis, Pete had the good oil

Sun Herald 5/02/2012 | INVESTORS cheered during the week, perhaps convinced that the latest rearrangement of deckchairs on the good ship euro will do the trick and right the heavily listing vessel.

If you can't beat banks, join 'em

Sun Herald 5/02/2012 | David Potts reveals why having a stake in a lender is so much more profitable than being its customer  dividends.

More...


Sponsored Links

More from our network...